The US Food and Drug Administration (FDA) has launched an initiative to reduce unnecessary radiation exposure from computed tomography (CT), nuclear medicine studies and fluoroscopy.
The goal of the FDA’s initiative is to support the benefits associated with medical imaging while minimising the risks.
The three-pronged initiative will promote the safe use of medical imaging devices, support informed clinical decision-making and increase patient awareness of exposure.
The FDA plans to issue targeted requirements for manufacturers of CT and fluoroscopic devices to include important safeguards in designing machines and to provide appropriate training to support their safe use by practitioners.
The FDA and the Centers for Medicare and Medicaid Services are collaborating to incorporate key quality assurance practices to improve the quality of oversight and promote the safe use of advanced imaging technologies.
CT, nuclear medicine studies and fluoroscopy are the greatest contributors to total radiation exposure within the US population and use much higher radiation doses than other radiographic procedures.